Qube Research & Technologies LTD Astria Therapeutics, Inc. Transaction History

Qube Research & Technologies LTD

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$8.97 - $12.65 $809,587 - $1.14 Million	-90,255 Reduced 75.42%	29,414 $323,000
Q2 2024 Aug 14, 2024	BUY	$8.83 - $13.51 $1.06 Million - $1.62 Million	119,669 New	119,669 $1.09 Million
Q1 2023 May 15, 2023	BUY	$11.2 - $15.79 $240,990 - $339,753	21,517 Added 171.44%	34,068 $453,000
Q4 2022 Feb 14, 2023	BUY	$7.44 - $14.89 $93,379 - $186,884	12,551 New	12,551 $186,000

115

50.3M

75K

6.2K

Ticker ATXS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 15,178,000
Market Cap $102M
Description
Astria Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutics for rare and niche allergic, and immunological diseases in the United States. Its lead product candidate is STAR-0215, a monoclonal antibody inhibitor of plasma kallikrein, which is in preclinical development stage...

Get notified when there are updates to the investment portfolio of Qube Research & Technologies LTD, based on Form 13F filings with the SEC.

Stay updated on Qube Research & Technologies LTD with notifications on news.